Testing Responsiveness to Platelet Inhibition on Chronic Antiplatelet Treatment For Acute Coronary Syndromes Trial
Status:
Completed
Trial end date:
2017-06-01
Target enrollment:
Participant gender:
Summary
This study investigates whether a platelet function testing guided approach with a short-term
(1 week) prasugrel treatment and a switch over to clopidogrel treatment in adequate
responders to clopidogrel is non-inferior regarding the combined incidence of bleeding and
thrombotic complications to a 12 month standard treatment with prasugrel in acute coronary
syndrome (ACS) patients treated with percutaneous coronary intervention (PCI).